‌

US Patent 8617546 Anticancer agent comprising anti-PD-1 antibody or anti-PD-L1 antibody

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

December 31, 2013

0

Patent Application Number

133989150

Date Filed

February 17, 2012

0

Patent Citations Received

US Patent 12077590 Bispecific antibody for cancer immunotherapy

0

US Patent 11951129 Compositions and methods for targeting CLEC12A-expressing cancers

0

US Patent 11993653 Antibodies and methods of use thereof

0

0

US Patent 11685782 Methods of treating cancer using LSD1 inhibitors in combination with immunotherapy

0

US Patent 11685775 Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody

0

US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors

0

US Patent 11707448 Combination therapies for the treatment of cancer

0

...

Patent Primary Examiner

Laura B Goddard

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8617546 Anticancer agent comprising anti-PD-1 antibody or anti-PD-L1 antibody

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.